Verastem, Inc. (VSTM): Price and Financial Metrics
Verastem, Inc. (VSTM)
Today's Latest Price: $1.88 USD
0.05 (2.73%)
Updated Jun 5 5:27pm
Add VSTM to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
VSTM Stock Summary
- VSTM's price/sales ratio is 14.27; that's higher than the P/S ratio of 91.13% of US stocks.
- With a year-over-year growth in debt of -54.41%, Verastem Inc's debt growth rate surpasses just 4.65% of about US stocks.
- As for revenue growth, note that VSTM's revenue has grown -26.59% over the past 12 months; that beats the revenue growth of merely 7.27% of US companies in our set.
- Stocks that are quantitatively similar to VSTM, based on their financial statements, market capitalization, and price volatility, are AMKR, TELL, IBIO, VJET, and NAV.
- VSTM's SEC filings can be seen here. And to visit Verastem Inc's official web site, go to www.verastem.com.
VSTM Daily Price Range
VSTM 52-Week Price Range
VSTM Stock Price Chart More Charts
VSTM Price/Volume Stats
| Current price | $1.88 | 52-week high | $4.67 |
| Prev. close | $1.83 | 52-week low | $0.83 |
| Day low | $1.80 | Volume | 6,785,039 |
| Day high | $1.91 | Avg. volume | 4,970,987 |
| 50-day MA | $2.37 | Dividend yield | N/A |
| 200-day MA | $1.76 | Market Cap | 305.56M |
Verastem, Inc. (VSTM) Company Bio
Verastem, Inc. focuses on discovering and developing drugs for the treatment of cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. The company was founded in 2010 and is based in Needham, Massachusetts.
Loading social stream, please wait...